Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Nov;99(5):1334-1340.
doi: 10.1213/01.ANE.0000134807.73615.5C.

The effects of propofol, small-dose isoflurane, and nitrous oxide on cortical somatosensory evoked potential and bispectral index monitoring in adolescents undergoing spinal fusion

Affiliations
Clinical Trial

The effects of propofol, small-dose isoflurane, and nitrous oxide on cortical somatosensory evoked potential and bispectral index monitoring in adolescents undergoing spinal fusion

Anthony J Clapcich et al. Anesth Analg. 2004 Nov.

Abstract

In this study we compared the effects of propofol, small-dose isoflurane, and nitrous oxide (N(2)O) on cortical somatosensory evoked potentials (SSEP) and bispectral index (BIS) monitoring in adolescents undergoing spinal fusion. Twelve patients received the following anesthetic maintenance combinations in a randomly determined order: treatment #1: isoflurane 0.4% + N(2)O 70% + O(2) 30%; treatment #2: isoflurane 0.6% + N(2)O 70% + O(2) 30%; treatment #3: isoflurane 0.6% + air + O(2) 30%; treatment #4: propofol 120 microg . kg(-1) . min(-1) + air + O(2) 30%. Cortical SSEP amplitudes measured during anesthesia maintenance with treatment #3 (isoflurane 0.6%/air) were more than those measured during maintenance with treatment #1 (isoflurane 0.4%/N(2)O 70%) (P < 0.0001) and treatment #2 (isoflurane 0.6%/N(2)O 70%) (P < 0.0052). Cortical SSEP amplitudes measured during treatment #4 (propofol 120 microg . kg(-1) . min(-1)/air) were more than treatment #1 (isoflurane 0.4%/N(2)O 70%) (P < 0.0001), treatment #2 (Iso 0.6%/N(2)O 70%) (P < 0.0007), and treatment #3 (isoflurane 0.6%/air) (P < 0.0191). In addition, average BIS values measured during treatments 1, 2, 3 and 4 were 62, 62, 61, and 44 respectively. Only treatment #4 (propofol 120 microg . kg(-1) . min(-1)/air) uniformly maintained BIS values less than 60. Our study demonstrates that propofol better preserves cortical SSEP amplitude measurement and provides a deeper level of hypnosis as measured by BIS values than combinations of small-dose isoflurane/N(2)O or small-dose isoflurane alone.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A, right posterior tibial cortical SSEPs recorded under anesthetic conditions of treatment #1 (isoflurane 0.4% + N2O 70% + O2 30%). B, right posterior tibial cortical SSEPs recorded on the same patient under anesthetic conditions of treatment #4 (propofol 120 μg · kg-1 · min-1 + air + O2 30%). Measurements of N34 amplitude (a) and P38 amplitude (b) are illustrated.
Figure 2
Figure 2
Mean cortical SSEP amplitude measurements for each anesthetic combination. Treatment #4 (propofol 120 μg · kg-1 · min-1 + air + O2 30%) allowed for significantly more robust cortical SSEP amplitude measurement than treatments 1, 2, and 3. The x-axis represents the four different anesthetic maintenance combinations studied: treatment #1, isoflurane 0.4% + N2O 70% + O2 30%; treatment #2, isoflurane 0.6% + N2O 70% + O2 30%; treatment #3, isoflurane 0.6% + air + O2 30%; treatment #4, propofol 120 μg · kg-1 · min-1 + air + O2 30%. The y-axis represents cortical SSEP amplitude size measured in microvolts. Each box plot represents the mean cortical SSEP amplitude value observed for each anesthetic maintenance combination. The lines that extend from the top and bottom of the box-plot represent the standard deviation in cortical SSEP amplitude values observed for each anesthetic maintenance combination.
Figure 3
Figure 3
Mean bispectral index (BIS) values observed for each anesthetic combination. Only treatment 4 consistently maintained BIS values below 60. The x-axis represents the four different anesthetic maintenance combinations studied: treatment #1, isoflurane 0.4% + N2O 70% + O2 30%; treatment #2, isoflurane 0.6% + N2O 70% + O2 30%; treatment #3, isoflurane 0.6% + air + O2 30%; treatment #4, propofol 120 μg · kg-1 · min-1 + air + O2 30%. The y-axis represents the BIS monitor values recorded for each of the four treatment groups. Each box plot represents the mean BIS value observed for each anesthetic maintenance combination. The lines that extend from the top and bottom of the box plot represent the standard deviation in BIS values observed for each anesthetic maintenance combination.

References

    1. Banoub M, Tetzlaff JE, Schubert A. Pharmacologic and physiologic influences affecting sensory evoked potentials. Anesthesiology. 2003;99:716–37. - PubMed
    1. Sebel PS, Ingram DA, Flynn PJ, et al. Evoked potentials during isoflurane anaesthesia. Br J Anaesth. 1986;58:580–5. - PubMed
    1. McPherson RW, Mahla M, Johnson R, Traystman RJ. Effects of enflurane, isoflurane, and nitrous oxide on somatosensory evoked potentials during fentanyl anesthesia. Anesthesiology. 1985;62:626–33. - PubMed
    1. Pathak KS, Ammadio M, Kalamachi A. Effects of halothane, enflurane, and isoflurane on somatosensory evoked potentials during nitrous oxide anesthesia. Anesthesiology. 1987;66:753–7. - PubMed
    1. Peterson DO, Drummond JC, Todd MM. Effects of halothane, enflurane, isoflurane, and nitrous oxide on somatosensory evoked potentials in humans. Anesthesiology. 1986;65:35–40. - PubMed

Publication types